Frühere Suchanfragen
Suchoptionen
@Lost_Paradise@troet.cafe@breitenbach Hat jetzt nichts mit der Energiekrise zu tun - oder nur indirekt - aber könntet ihr euch das bitte einmal ansehen?
- - - - - > https://troet.cafe/@Lost_Paradise/109521733896405773
Ich würde mich über einen #Faktencheck und weitere Verarbeitung sehr freuen! #Thank #YOU
![Tatsächliche Historie?
Wert des Unternehmens heute?
Wieviele und welche Patente?
DEA-Verbindung?
Genom-Entschlüsselung-Cannabis?
Biovia?
Endocannabinoidsystem - Immunsystem?
Neue Medikamente auf Basis Endocannabinoidsystem?
Patente?
Billionenmarkt?
Quantephysik - Quantenchemie?
6630507?
6630507?
History
GW Pharmaceuticals was founded in 1998 by doctors Geoffrey Guy and Brian Whittle. That year, they obtained a cultivation license from the United Kingdom Home Office and the MHRA, allowing the company to cultivate, possess and supply cannabis to conduct scientific research concerning medical cannabis.[4]
Later in 1998, GW Pharmaceuticals entered into a contract with Hortapharm B.V., a cannabis research and development corporation based in Amsterdam.[5][6]
In 2001, GW Pharmaceuticals listed on the Alternative Investment Market, the junior market of the London Stock Exchange.[7] In May 2013, the company became dual-listed on the NASDAQ and AIM.[8]
In 2014, the company made a deal with New York to develop clinical trials using cannabidiol (CBD) to treat children who suffer from seizures and other medical complications.[9]
In May 2021, Jazz Pharmaceuticals acquired the company.[10][11]](https://media.troet.cafe/troet.cafe/media_attachments/files/109/522/752/137/524/639/original/7a5d6e2ff79d540a.png "Tatsächliche Historie?
Wert des Unternehmens heute?
Wieviele und welche Patente?
DEA-Verbindung?
Genom-Entschlüsselung-Cannabis?
Biovia?
Endocannabinoidsystem - Immunsystem?
Neue Medikamente auf Basis Endocannabinoidsystem?
Patente?
Billionenmarkt?
Quantephysik - Quantenchemie?
6630507?
6630507?
History
GW Pharmaceuticals was founded in 1998 by doctors Geoffrey Guy and Brian Whittle. That year, they obtained a cultivation license from the United Kingdom Home Office and the MHRA, allowing the company to cultivate, possess and supply cannabis to conduct scientific research concerning medical cannabis.[4]
Later in 1998, GW Pharmaceuticals entered into a contract with Hortapharm B.V., a cannabis research and development corporation based in Amsterdam.[5][6]
In 2001, GW Pharmaceuticals listed on the Alternative Investment Market, the junior market of the London Stock Exchange.[7] In May 2013, the company became dual-listed on the NASDAQ and AIM.[8]
In 2014, the company made a deal with New York to develop clinical trials using cannabidiol (CBD) to treat children who suffer from seizures and other medical complications.[9]
In May 2021, Jazz Pharmaceuticals acquired the company.[10][11]")
ALT